NATIONAL RESEARCH CORP (NRC)

US6373722023 - Common Stock

34.64  +0.39 (+1.14%)

After market: 34.64 0 (0%)

Fundamental Rating

6

Taking everything into account, NRC scores 6 out of 10 in our fundamental rating. NRC was compared to 117 industry peers in the Health Care Providers & Services industry. NRC has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NRC is valued expensive and it does not seem to be growing.



9

1. Profitability

1.1 Basic Checks

NRC had positive earnings in the past year.
In the past year NRC had a positive cash flow from operations.
In the past 5 years NRC has always been profitable.
NRC had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

NRC has a better Return On Assets (25.28%) than 97.41% of its industry peers.
The Return On Equity of NRC (63.23%) is better than 97.41% of its industry peers.
NRC has a better Return On Invested Capital (71.35%) than 100.00% of its industry peers.
NRC had an Average Return On Invested Capital over the past 3 years of 50.45%. This is significantly above the industry average of 8.60%.
The 3 year average ROIC (50.45%) for NRC is below the current ROIC(71.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 25.28%
ROE 63.23%
ROIC 71.35%
ROA(3y)24.47%
ROA(5y)26.09%
ROE(3y)50.42%
ROE(5y)61.46%
ROIC(3y)50.45%
ROIC(5y)45.57%

1.3 Margins

With an excellent Profit Margin value of 20.83%, NRC belongs to the best of the industry, outperforming 95.69% of the companies in the same industry.
NRC's Profit Margin has declined in the last couple of years.
NRC's Operating Margin of 54.56% is amongst the best of the industry. NRC outperforms 100.00% of its industry peers.
NRC's Operating Margin has improved in the last couple of years.
NRC's Gross Margin of 62.29% is amongst the best of the industry. NRC outperforms 86.21% of its industry peers.
In the last couple of years the Gross Margin of NRC has remained more or less at the same level.
Industry RankSector Rank
OM 54.56%
PM (TTM) 20.83%
GM 62.29%
OM growth 3Y19.88%
OM growth 5Y13.09%
PM growth 3Y-9.28%
PM growth 5Y-3.56%
GM growth 3Y-0.42%
GM growth 5Y0.68%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NRC is creating value.
The number of shares outstanding for NRC has been reduced compared to 1 year ago.
The number of shares outstanding for NRC has been reduced compared to 5 years ago.
NRC has a worse debt/assets ratio than last year.

2.2 Solvency

NRC has an Altman-Z score of 9.60. This indicates that NRC is financially healthy and has little risk of bankruptcy at the moment.
NRC has a Altman-Z score of 9.60. This is amongst the best in the industry. NRC outperforms 95.69% of its industry peers.
The Debt to FCF ratio of NRC is 1.64, which is an excellent value as it means it would take NRC, only 1.64 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NRC (1.64) is better than 87.07% of its industry peers.
NRC has a Debt/Equity ratio of 0.60. This is a neutral value indicating NRC is somewhat dependend on debt financing.
NRC has a Debt to Equity ratio (0.60) which is in line with its industry peers.
Although NRC does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 1.64
Altman-Z 9.6
ROIC/WACC7.91
WACC9.02%

2.3 Liquidity

A Current Ratio of 0.67 indicates that NRC may have some problems paying its short term obligations.
NRC's Current ratio of 0.67 is on the low side compared to the rest of the industry. NRC is outperformed by 82.76% of its industry peers.
A Quick Ratio of 0.67 indicates that NRC may have some problems paying its short term obligations.
NRC has a Quick ratio of 0.67. This is in the lower half of the industry: NRC underperforms 77.59% of its industry peers.
NRC does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.67

1

3. Growth

3.1 Past

NRC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.57%.
Measured over the past 5 years, NRC shows a small growth in Earnings Per Share. The EPS has been growing by 3.24% on average per year.
Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -1.97% in the last year.
Measured over the past years, NRC shows a small growth in Revenue. The Revenue has been growing by 4.42% on average per year.
EPS 1Y (TTM)-1.57%
EPS 3Y-4.7%
EPS 5Y3.24%
EPS growth Q2Q33.33%
Revenue 1Y (TTM)-1.97%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Revenue growth Q2Q-0.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

NRC is valuated quite expensively with a Price/Earnings ratio of 27.71.
NRC's Price/Earnings ratio is a bit cheaper when compared to the industry. NRC is cheaper than 66.38% of the companies in the same industry.
When comparing the Price/Earnings ratio of NRC to the average of the S&P500 Index (24.55), we can say NRC is valued inline with the index average.
Industry RankSector Rank
PE 27.71
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NRC is valued a bit cheaper than 79.31% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NRC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 36.99
EV/EBITDA 9.74

4.3 Compensation for Growth

The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)8.55
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.43%, NRC has a reasonable but not impressive dividend return.
NRC's Dividend Yield is rather good when compared to the industry average which is at 2.73. NRC pays more dividend than 87.07% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, NRC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.43%

5.2 History

The dividend of NRC is nicely growing with an annual growth rate of 16.85%!
NRC has paid a dividend for at least 10 years, which is a reliable track record.
NRC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)16.85%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

117.48% of the earnings are spent on dividend by NRC. This is not a sustainable payout ratio.
NRC's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP117.48%
EPS Next 2YN/A
EPS Next 3YN/A

NATIONAL RESEARCH CORP

NASDAQ:NRC (5/1/2024, 7:13:07 PM)

After market: 34.64 0 (0%)

34.64

+0.39 (+1.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap826.16M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.43%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 27.71
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)8.55
Profitability
Industry RankSector Rank
ROA 25.28%
ROE 63.23%
ROCE
ROIC
ROICexc
ROICexgc
OM 54.56%
PM (TTM) 20.83%
GM 62.29%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.67
Quick Ratio 0.67
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1.57%
EPS 3Y-4.7%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.97%
Revenue growth 3Y3.68%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y